JPRN-UMIN000006589已完成4 期
Investigation of inhaled Salmeterol/ Fluticasone propionate (SFC) in patient with COPD. - SFC for COPD
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 342
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •History of hyper- sensitivity to Salmeterol/ Fluticasone propionate Patients with bronchial asthma Patients during acute exacerbation Presence of infectious disease, pneumothorax, and severe heart failure
研究者
相似试验
已完成
不适用
The efficacy of salmeterol/fluticasone inhalation on systemic inflammatory markers in patients with chronic obstructive pulmonary diseaseschronic obstructive pulmonary diseasesJPRN-UMIN000008102Kawasaki Medical School60
已完成
不适用
Bronchodilator effects of salmeterol/fluticasone propionate (SFC) in patients with COPDCOPDJPRN-UMIN000002764Atami Hospita International University of Health and Welfare30
进行中（未招募）
1 期
ptake and excretion of salmeterol in healthy trained malesEUCTR2014-002139-33-DKBispebjerg University Hospital
已完成
4 期
Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis BronchiectasisBronchiectasisNCT02782312Shanghai Pulmonary Hospital, Shanghai, China120
已完成
不适用
Assessments of the effect of Salmeterol and Fluticasone Propionate (SFC250) on the patients with chronic obstructive pulmonary disease by Impulse OscillometryChronic Obstructive Pulmonary DiseaseJPRN-UMIN000004196St. Marianna University School of Medicine, Division of Respiratory and Infectious Diseases200